Spago Nanomedical AB (publ) (STO:SPAGO)
0.1265
-0.0060 (-4.53%)
Feb 11, 2026, 9:36 AM CET
Spago Nanomedical AB Revenue
Spago Nanomedical AB had revenue of 833.00K SEK in the quarter ending December 31, 2025, a decrease of -55.07%. This brings the company's revenue in the last twelve months to 5.84M, down -16.35% year-over-year. In the year 2024, Spago Nanomedical AB had annual revenue of 6.65M with 17.94% growth.
Revenue (ttm)
5.84M
Revenue Growth
-16.35%
P/S Ratio
18.18
Revenue / Employee
602.75K
Employees
8
Market Cap
87.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.65M | 1.01M | 17.94% |
| Dec 31, 2023 | 5.64M | -562.00K | -9.06% |
| Dec 31, 2022 | 6.20M | -279.00K | -4.30% |
| Dec 31, 2021 | 6.48M | -679.00K | -9.48% |
| Dec 31, 2020 | 7.16M | -11.80M | -62.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alligator Bioscience AB | 46.22M |
| Alzinova AB | 26.12M |
| Scandinavian ChemoTech AB | 11.68M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Biovica International AB | 9.89M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 2.30M |
| Pila Pharma AB | 957.89K |